Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TRIB |
---|---|---|
09:32 ET | 750 | 1.34 |
09:33 ET | 8162 | 1.38 |
09:35 ET | 100 | 1.4 |
09:39 ET | 500 | 1.42 |
09:46 ET | 900 | 1.42 |
09:50 ET | 100 | 1.4556 |
09:55 ET | 200 | 1.4001 |
10:00 ET | 178 | 1.47 |
10:02 ET | 2151 | 1.53 |
10:04 ET | 2000 | 1.43 |
10:06 ET | 2530 | 1.39 |
10:20 ET | 200 | 1.465 |
10:24 ET | 100 | 1.47 |
10:33 ET | 500 | 1.401 |
10:36 ET | 618 | 1.4347 |
10:42 ET | 150 | 1.4562 |
10:45 ET | 1000 | 1.436 |
10:56 ET | 200 | 1.44 |
11:16 ET | 433 | 1.3951 |
11:18 ET | 100 | 1.42 |
11:25 ET | 1095 | 1.395 |
11:27 ET | 100 | 1.4 |
11:36 ET | 1857 | 1.34 |
11:38 ET | 1000 | 1.408 |
11:39 ET | 1201 | 1.405 |
11:45 ET | 3000 | 1.4044 |
12:01 ET | 200 | 1.35 |
12:03 ET | 426 | 1.4 |
12:17 ET | 1473 | 1.4377 |
12:33 ET | 331 | 1.4 |
12:39 ET | 200 | 1.4174 |
12:42 ET | 2000 | 1.4 |
12:50 ET | 2000 | 1.3954 |
12:51 ET | 490 | 1.39 |
01:04 ET | 100 | 1.3801 |
01:11 ET | 215 | 1.4399 |
01:13 ET | 2400 | 1.41 |
01:24 ET | 100 | 1.3801 |
01:29 ET | 885 | 1.38 |
02:05 ET | 796 | 1.4 |
03:17 ET | 175 | 1.38 |
03:19 ET | 2022 | 1.3601 |
03:37 ET | 100 | 1.4253 |
03:42 ET | 1000 | 1.3601 |
03:57 ET | 546 | 1.37 |
04:00 ET | 301 | 1.37 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Trinity Biotech PLC | 15.6M | -0.5x | --- |
Retractable Technologies Inc | 18.4M | -1.0x | --- |
Minerva Surgical Inc | 10.0 | 0.0x | --- |
Sonendo Inc | 882.1K | 0.0x | --- |
DIH Holding US Inc | 40.5M | -5.3x | --- |
Dalrada Financial Corp | 4.2M | -0.2x | --- |
Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.6M |
---|---|
Revenue (TTM) | $58.7M |
Shares Outstanding | 2.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $-2.74 |
Book Value | $-15.67 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -26.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.